519
Views
7
CrossRef citations to date
0
Altmetric
Review

Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review

, , , , &
Pages 2335-2352 | Published online: 20 May 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ruirui Zhang, Hao Zhang, Houyin Shi, Dan Zhang, Zhuo Zhang & Hao Liu. (2022) Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges. Drug Delivery 29:1, pages 3052-3070.
Read now

Articles from other publishers (6)

Xu Guo, Congying Gao, Dong-Hua Yang & Shenglong Li. (2023) Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance. Drug Resistance Updates 67, pages 100937.
Crossref
Arshi Khanam & Shyam Kottilil. (2022) New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?. International Journal of Molecular Sciences 24:1, pages 437.
Crossref
Zhao-Shan Niu, Wen-Hong Wang & Xiao-Jun Niu. (2022) Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma. World Journal of Gastroenterology 28:46, pages 6433-6477.
Crossref
Jingxin Yan, Manjun Deng, Ting Li, Yaxuan Wang, Jiaxin Wu, LuShun Zhang & Haining Fan. (2022) Transarterial chemoembolisation plus I125 seeds implantation for people with unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2022:12.
Crossref
Xiaolong Li, Shijie Ma, Ting Gao, Yaping Mai, Zhihua Song & Jianhong Yang. (2022) The main battlefield of mRNA vaccine – Tumor immune microenvironment. International Immunopharmacology 113, pages 109367.
Crossref
Xiaomeng Zou, Tiantian Li, Yingxuan Mao, Mingwei Zhu, Xi Chen, Jiamei Niu, Tianxiu Dong, Jian Jiang & Xiuhua Yang. (2022) Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells. BioMed Research International 2022, pages 1-18.
Crossref